Coherus Oncology, Inc 10-K for FY2019
Coherus Oncology, Inc. (CHRS)
10-K
2020-02-27
For: 2019-12-31
View Original
Added on
April 09, 2026
About this 10-K
Coherus Oncology, Inc filed this 10-K on February 27, 2020, covering the fiscal year ended December 31, 2019 (FY2019).
Headline figures
Fiscal year ended December 31, 2019, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $356.07M
- compared with $0 a year earlier
- Net income
- $89.83M
- compared with a net loss of $209.34M a year earlier
- Diluted EPS
- $1.23
- compared with -$3.22 a year earlier